Chinese AI System Designed to Predict Diabetes Years in Advance
By HospiMedica International staff writers Posted on 24 Sep 2018 |
4 Paradigm (Beijing, China), a technology company, is working with Ruijin Hospital (Shanghai, China) to develop a new artificial intelligence (AI) system that will help them to identify patients at risk of developing diabetes up to 15 years in advance. The model named Ruining Knows Sugar, or Ruining Zhitang in Chinese, has achieved an accuracy rate of 88% in tests.
Designed to identify those most at risk of developing type 2 diabetes within the next three years, the system also provided risk forecasts for the next nine and 15 years as a reference. For the tests, the new system used medical information from 170,000 individuals from across the country, some of who had diabetes and others did not. The data collected by the hospital’s diabetes research team between 2010 and 2013 included gender, height, weight, blood sugar levels, smoking and drinking history, and education levels. The AI algorithm then used that information to make its predictions and “learned” from the results.
The use of AI to help predict and monitor diabetes is growing. For instance, in June 2018, medical device company Medtronic along with IBM Waston Health released its Sugar.IQ app, which evaluates how a user’s blood sugar levels respond to variables such as food intake, insulin dosing and other daily routines.
Related Links:
4 Paradigm
Ruijin Hospital
Designed to identify those most at risk of developing type 2 diabetes within the next three years, the system also provided risk forecasts for the next nine and 15 years as a reference. For the tests, the new system used medical information from 170,000 individuals from across the country, some of who had diabetes and others did not. The data collected by the hospital’s diabetes research team between 2010 and 2013 included gender, height, weight, blood sugar levels, smoking and drinking history, and education levels. The AI algorithm then used that information to make its predictions and “learned” from the results.
The use of AI to help predict and monitor diabetes is growing. For instance, in June 2018, medical device company Medtronic along with IBM Waston Health released its Sugar.IQ app, which evaluates how a user’s blood sugar levels respond to variables such as food intake, insulin dosing and other daily routines.
Related Links:
4 Paradigm
Ruijin Hospital
Latest Business News
- Johnson & Johnson Acquires Cardiovascular Medical Device Company Shockwave Medical
- Mindray to Acquire Chinese Medical Device Company APT Medical
- Olympus Acquires Korean GI Stent Maker Taewoong Medical
- Karl Storz Acquires British AI Specialist Innersight Labs
- Stryker to Acquire French Joint Replacement Company SERF SAS
- Medical Illumination Acquires Surgical Lighting Specialist Isolux
- 5G Remote-Controlled Robots to Enable Even Cross-Border Surgeries
- International Hospital Federation Announces 2023 IHF Award Winners
- Unprecedented AI Integration Transforming Surgery Landscape, Say Experts
- New WHO Guidelines to Revolutionize AI in Healthcare
- Getinge Acquires US-Based Medical Equipment Provider Healthmark Industries
- Global Surgical Lights Market Driven by Increasing Number of Procedures
- Global Capsule Endoscopy Market Driven by Demand for Accurate Diagnosis of Gastrointestinal Conditions
- Global OR Integration Market Driven by Need for Improved Workflow Efficiency and Productivity
- Global Endoscopy Devices Market Driven by Increasing Adoption of Endoscopes in Surgical Procedures
- Global Minimally Invasive Medical Devices Market Driven by Benefits of MIS Procedures